To further validate our results, we treated the breast cancer cells with exogenous Nesfatin-1 or vehicle and found that the lysate cholesterol concentration increased dose-dependently with Nesfatin-1 treatment (Fig. 4C). Here, NUCB2 is linked to breast carcinoma.